Northern Trust’s Mateon Therapeutics, Inc. MATN Stock Holding History

Northern Trust’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,499	Closed	-$16K	–	4230
2016 Q3	$16K	Hold	25,499	–	–	﹤0.01%	4119
2016 Q2	$17K	Buy	+25,499	New	+$18.1K	﹤0.01%	4131

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Northern Trust's MATN Position: Q4 2016 in Review

Northern Trust sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 25,499 shares — an estimated $16K sold.

Northern Trust first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $17K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Northern Trust reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Northern Trust sold 25,499 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $16K.
Northern Trust first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Northern Trust's Mateon Therapeutics, Inc. position peaked at $17K in Q2 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.